MedPath
FDA Approval

Ella

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ulipristal(30 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RPK Pharmaceuticals, Inc.

RPK Pharmaceuticals, Inc.

147096275

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ella

Product Details

NDC Product Code
53002-2630
Application Number
NDA022474
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
May 11, 2020
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
Code: YF7V70N02BClass: ACTIBQuantity: 30 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath